Career Opportunities at MRC-Holland
MRC-Holland is a fast-growing biotechnology company based in the Amsterdam Baarsjes. MRC-Holland consists of a multinational team of more than 80 employees. MRC-Holland is the inventor of the Multiplex Ligation-dependent Probe Amplification (MLPA) technique, a sensitive method to detect copy number changes in genes. MLPA is used in hundreds of labs and hospitals worldwide for many different applications, including mutation detection in hereditary diseases and subtyping of tumours. Because of continuous growth, we are looking for:

new products
P476-ZNRF3
Adrenocortical tumours and other solid tumours
P479-TCF12 - ERF
Craniofacial disorders
improved products
P260-PALB2-RAD50-RAD51C-RAD51D
Hereditary predisposition to Cancer
P103-DPYD
Dihydropyrimidine dehydrogenase (DPYD) deficiency
P152-ABCA4 mix-2
Stargardt, Macular dystrophy, Retinitis pigmentosa, age-related macular degeneration, cone rod dystrophies
P151-ABCA4 mix-1
Stargardt, Macular dystrophy, Retinitis pigmentosa, age-related macular degeneration, cone rod dystrophies
P267-Dandy-Walker
Dandy-Walker Malformation (DWM)
P226-SDH
Paragangliomas (PGL)
P335-ALL-IKZF1
ALL
P340-EHMT1
9q subtelomeric deletion syndrome (9qSTDS) or Kleefstra syndrome.
P378-MUTYH
Colon cancer, stomach cancer (hereditary)
Newsletter  |  Home  |  Site map  |  Terms and Conditions  |  Search  |  Copyright © 2018 MRC-Holland